|
?:authorAffiliation
|
-
[\'Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.\', \'Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.\', \'Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH \'s-Hertogenbosch, The Netherlands.\', \'Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0315 Oslo, Norway.\', \'Department of Child Health and Development, Norwegian Institute of Public Health, 0403 Oslo, Norway.\', \'Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.\', \'Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland.\', \'Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.\', \'School of Health Sciences (HESAV) Midwifery Department, University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}